MetaCap

Biotechnology: Pharmaceutical Preparations Stocks

436 biotechnology: pharmaceutical preparations stocks ranked by market capitalization, page 5 of 9. Updated October 11, 2026.

Today
+1.28%

Biotechnology: Pharmaceutical Preparations stocks ranked 201–250

Biotechnology: Pharmaceutical Preparations stocks by market cap
#SymbolCompanyPrice% ChangeVolumeMarket Cap
201ALTAltimmune Inc.2.61+0.38%2.68M$507.69M
202CTNMContineum Therapeutics Inc. Class A13.38+1.52%885.59K$503.37M
203ARVNArvinas Inc.7.64+1.73%560.05K$492.94M
204MPLTMapLight Therapeutics Inc.8.83-3.50%495.36K$490.73M
205OVIDOvid Therapeutics Inc.2.46+5.13%1.41M$480.43M
206ASMBAssembly Biosciences Inc.23.53+3.11%170.49K$479.08M
207RZLTRezolute Inc.4.87+4.96%1.87M$471.04M
208KMDAKamada Ltd.8.08+3.92%72.77K$466.30M
209CAPRCapricor Therapeutics Inc.7.83-2.25%1.70M$455.23M
210PRTAProthena Corporation plc8.84+2.67%931.63K$453.82M
211DMACDiaMedica Therapeutics Inc.8.33+4.00%170.15K$449.20M
212SPRYARS Pharmaceuticals Inc.4.23-7.24%1.26M$420.66M
213AVIRAtea Pharmaceuticals Inc.5.15-0.10%157.97K$413.05M
214GALTGalectin Therapeutics Inc.3.94+8.24%156.51K$397.35M
215ARCTArcturus Therapeutics Holdings Inc.13.74+6.76%675.69K$390.53M
216IRDOpus Genetics Inc.4.65+4.26%1.26M$386.86M
217TTRXTurn Therapeutics Inc.12.00+5.36%109.83K$364.41M
218ENTAEnanta Pharmaceuticals Inc.12.50+3.31%182.07K$364.07M
219EBSEmergent BioSolutions Inc.7.06+3.67%848.21K$361.99M
220RLMDRelmada Therapeutics Inc.3.39+6.94%1.73M$361.61M
221INDPIndaptus Therapeutics Inc.2.51+5.91%467.60K$334.44M
222CYPHCypherpunk Technologies Inc.2.94+4.63%10.26M$316.83M
223PRLDPrelude Therapeutics Incorporated3.89+0.26%341.65K$310.44M
224BNTCBenitec Biopharma Inc.8.87+1.37%73.14K$309.41M
225CATXPerspective Therapeutics Inc.2.66-1.84%1.10M$303.64M
226BIOABioAge Labs Inc.6.34+2.09%667.34K$290.99M
227FULCFulcrum Therapeutics Inc.3.77+0.53%1.80M$287.96M
228ABEOAbeona Therapeutics Inc.4.94-0.40%1.28M$282.49M
229RCKTRocket Pharmaceuticals Inc.2.56-2.66%3.37M$281.02M
230LRMRLarimar Therapeutics Inc.2.67-1.11%868.88K$277.37M
231VNDAVanda Pharmaceuticals Inc.4.57+0.88%640.26K$276.31M
232BCYCBicycle Therapeutics plc ADR3.89+2.10%300.62K$272.27M
233BBOTBridgeBio Oncology Therapeutics Inc.3.31-3.22%471.95K$265.38M
234VOGXVogenx Inc17.56+0.40%77.19K$260.86M
235ZNTLZentalis Pharmaceuticals Inc.2.64+5.18%612.37K$259.04M
236UPBUpstream Bio Inc.4.70+3.30%1.19M$257.42M
237IMRXImmuneering Corporation Class A3.94+5.35%709.72K$254.91M
238AMRNAmarin Corporation plc12.03+0.33%44.85K$254.11M
239VCREVicore Pharma Holding AB ADR9.00+2.04%30.98K$253.48M
240ACIUAC Immune SA2.50-1.96%271.32K$248.57M
241QTTBQ32 Bio Inc.8.34+3.09%854.92K$248.28M
242LFCRLifecore Biomedical Inc.6.45+0.31%387.10K$244.49M
243GLSIGreenwich LifeSciences Inc.16.53+9.18%119.88K$242.63M
244PYXSPyxis Oncology Inc.2.03+2.01%950.41K$242.50M
245MGNXMacroGenics Inc.3.74+5.35%418.44K$238.24M
246KROSKeros Therapeutics Inc.11.95+2.66%194.39K$236.93M
247CAMPCAMP4 Therapeutics Corporation3.77+1.89%72.15K$236.58M
248IFRXInflaRx N.V.1.60+4.58%740.71K$235.79M
249SIGASIGA Technologies Inc.3.280.00%464.98K$235.67M
250SLGLSol-Gel Technologies Ltd.71.77+2.03%31.47K$234.97M

Explore more

Prices as of Oct 11, 5:50 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer